Modification of tumor cells to secrete interferon (IFN)-γ resulted in the induction of persistent specific T cell immunity and a CD8+ T cell-dependent tumor rejection whereas treatment of wild type mice with antibodies to neutralize endogenous IFN-γ led to failed rejection of carcinogen-induced tumors[10-12]. This evidence concerns the gene IFNG and neoplasm.